Knight Therapeutics (KHTRF) Q3 2024 Earnings

8AugConfirmed
Nov 22
Q4 2023
Q2 2024
Q3 2024
-0.17
-0.11
-0.05
0.02

Details

Expected EPS
0.0173051681
Actual EPS
-0.014614
Surprise EPS
-0.03
Surprise Percent
+184.45%

Description

Knight Therapeutics (KHTRF) has reported earnings of -0.014614 per share for Q3 2024.

0 Comments

Share your thoughts